Located in Jing’an, Jiangxi province, Jiangxi Baoling Animal Health Co., Ltd. is a national high-tech enterprise specialized in the research, production, and sales of animal healthcare products. It occupies a total area of 43 Chinese acres (approx. 28,611 ㎡), with a total construction area of 55,180 ㎡ and a total investment of approximately 210 million RMB. Baoling has been certified as a “Specialized, Refined, Differentiated, and Innovative” enterprise in Jiangxi Province, as well as an enterprise with integration of Information and Industrialization. It has also been recognized as a Technological Innovation Center of Yichun City.

        Our company covers a wide range of commonly used veterinary drug formulations for large-scale farming, as well as feed additives, pet drugs, and nutritional supplements. It is an integrated enterprise that combines production, research, development, and sales. Our company has 26 production lines, including intravenous and non-intravenous injections, powder injections, oral solutions, sprays, powders, premixes, dispersible powders, granules, tablets, non-chlorine disinfectants, external insecticides, topical ointments, creams, eye drops, ear drops, and traditional Chinese medicine extracts. All production lines have passed the latest Veterinary GMP certification issued by the Ministry of Agriculture and Rural Affairs, as well as CAQI (China Association for Quality Inspection) quality inspections.

        Our Company has established an industry-academia-research cooperation base with the College of Animal Science and Technology of Jiangxi Agricultural University, and has signed strategic cooperation agreements with China Agricultural University and other prestigious institutions. Each year, the company invests millions of RMB in R&D to maintain product competitiveness. Currently, it holds six national new veterinary drug certificates, with several more in Phase II clinical trials and over a dozen under application. A total of 212 approved products have been registered. The company’s annual production capacity includes 41.6 million bottles of powder injections, 21.625 million vials of aqueous injections, 89.4 million tablets, and 1.2 million tubes of ointments. Baoling also masters advanced technologies such as microencapsulation, coating, and long-acting sustained release, supported by state-of-the-art manufacturing equipment—laying a solid foundation to become a first-class veterinary pharmaceutical group in China.